Therapeutic Asset Ratings
129 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
kj015
Head And Neck Squamous Cell Carcinoma
Shanghai Bao Pharmaceuticals Co., Ltd.
P1
C
(37)
LNTH-2403
Head And Neck Squamous Cell Carcinoma
Radiopharm Theranostics, Ltd
P1
C
(37)
[Lu-177]-Pnt6555
Head And Neck Squamous Cell Carcinoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
P1
C
(37)
Lutetium [177Lu] Bl-Arc001
Head And Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(37)
ly4052031
Head And Neck Squamous Cell Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4101174
Head And Neck Squamous Cell Carcinoma
Eli Lilly and Company
P1
C
(37)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Head And Neck Squamous Cell Carcinoma
City of Hope Medical Center
P1
C
(37)
mq719
Head And Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
C
(37)
Naptumomab Estafenatox
Head And Neck Squamous Cell Carcinoma
NeoTX Therapeutics Ltd.
P1
C
(37)
Onm-501
Head And Neck Squamous Cell Carcinoma
OncoNano Medicine, Inc.
P1
C
(37)
pf-08046032
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
C
(37)
P-Muc1C-Allo1 Car-T Cells
Head And Neck Squamous Cell Carcinoma
Poseida Therapeutics, Inc.
P1
C
(37)
qls5316
Head And Neck Squamous Cell Carcinoma
Qilu Pharmaceutical Co., Ltd.
P1
C
(37)
RC198
Head And Neck Squamous Cell Carcinoma
RemeGen Co., Ltd.
P1
C
(37)
Rimiducid
Head And Neck Squamous Cell Carcinoma
Poseida Therapeutics, Inc.
P1
C
(37)
Rph-075
Head And Neck Squamous Cell Carcinoma
R-Pharm
P1
C
(37)
sim0610 for
Head And Neck Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
P1
C
(37)
Tbio-4101
Head And Neck Squamous Cell Carcinoma
Turnstone Biologics, Corp.
P1
C
(37)
Telisotuzumab Adizutecan
Head And Neck Squamous Cell Carcinoma
AbbVie
P1
C
(37)
Tilt-123
Head And Neck Squamous Cell Carcinoma
TILT Biotherapeutics Ltd.
P1
C
(37)
vet3-tgi
Head And Neck Squamous Cell Carcinoma
KaliVir Immunotherapeutics
P1
C
(37)
zm008
Head And Neck Squamous Cell Carcinoma
Zumutor Biologics Inc.
P1
C
(37)
Pba-0405
Head And Neck Squamous Cell Carcinoma
Pure Biologics S.A.
Early P1
C
(37)
Fosifloxuridine Nafalbenamide
Head And Neck Squamous Cell Carcinoma
NuCana plc
P1/2
C
(35)
18F-ASIS
Head and Neck Squamous Cell Carcinoma
Var2 Pharmaceuticals
Early P1
C
(34)
Showing 101 to 125 of 129 assets
Previous
Page 5 of 6
Next
